A short trial of a synthetic cannabinoid for people with advanced cancer was shown to improve caloric intake, appetite, and sensory perceptions around food, as well as quality of life.
As hospice managers face the advent of quality reporting programs, Quality Assessment and Performance Improvement (QAPI) programs are being evaluated to ensure the capability to meet requirements for Medicare programs.
The use of biomarkers from the CSF, as well as newer PET imaging ligands, allow for an accurate diagnosis in patients who have a syndrome of posterior cortical atrophy.
